Aker Biomarine Sustainability Profile
Aker BioMarine, a leading biotechnology company headquartered in Norway, is renowned for its innovative approach to sustainable marine ingredients. Founded in 2006, the company has established itself as a key player in the aquaculture and nutraceutical industries, focusing on the harvesting and processing of krill. Aker BioMarine operates primarily in the Southern Ocean, where it utilises advanced, eco-friendly methods to ensure the sustainability of its operations. The company’s flagship products, including krill oil and krill meal, are distinguished by their high-quality omega-3 fatty acids and unique antioxidant properties. Aker BioMarine's commitment to sustainability and responsible sourcing has earned it a prominent position in the global market, making it a trusted partner for health and wellness brands. With a strong emphasis on research and development, Aker BioMarine continues to lead the way in marine biotechnology, contributing to both human health and environmental stewardship.
DitchCarbon Score
How does Aker Biomarine's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Aker Biomarine's score of 52 is higher than 73% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Aker Biomarine's reported carbon emissions
In 2024, Aker BioMarine, headquartered in Norway, reported total carbon emissions of approximately 23,673,000 kg CO2e. This figure includes 4,320,000 kg CO2e from Scope 1 emissions, 4,062,000 kg CO2e from Scope 2 emissions, and a significant 15,291,000 kg CO2e from Scope 3 emissions. In 2023, the company disclosed total emissions of about 110,845,000 kg CO2e, with Scope 1 emissions at 93,981,000 kg CO2e, Scope 2 emissions at 3,698,000 kg CO2e, and Scope 3 emissions at 13,166,000 kg CO2e. Notably, in the same year, Aker BioMarine reported Scope 2 emissions of 28,000 kg CO2e in Norway, 33,000 kg CO2e in India, and 3,601,000 kg CO2e in the United States. Despite the substantial emissions figures, Aker BioMarine has not set specific reduction targets or initiatives as part of their climate commitments. The company is a current subsidiary of Aker BioMarine AS, with emissions data cascaded from the parent company Aker ASA at a cascade level of 2. Overall, Aker BioMarine's emissions profile reflects the challenges faced by the marine biotechnology sector in addressing climate change, with a significant reliance on Scope 3 emissions, which often represent the largest share of total emissions for companies in this industry.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | 77,461,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 0,000,000 |
| Scope 2 | 4,296,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 3 | 8,870,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
How Carbon Intensive is Aker Biomarine's Industry?
How Carbon Intensive is Aker Biomarine's Location?
Aker Biomarine's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Aker Biomarine has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
